Skip to main content

Table 4 Recovery study

From: Development and validation of stability-indicating RP-HPLC method for the simultaneous estimation of xylometazoline hydrochloride and ipratropium bromide from nasal spray dosage form

  Xylometazoline Ipratropium bromide
Recovery level in % % Recovery % Average recovery % Recovery % Average recovery
50% 99.7 99.4 98.5 98.3
99.2 98.3
99.4 98.2
100% 101.2 101.1 101.4 101.3
101.3 101.4
100.9 101.2
150% 101.6 101.6 101.6 101.5
101.5 101.5
101.6 101.5